Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study

BACKGROUND: Long-term treatment with riociguat has been shown to enhance exercise capacity in patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH). This study sought to evaluate the long-term haemodynamic eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Suqiao, Yang, Yuanhua, Zhang, Yixiao, Kuang, Tuguang, Gong, Juanni, Li, Jifeng, Li, Yidan, Wang, Jianfeng, Guo, Xiaojuan, Miao, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419318/
https://www.ncbi.nlm.nih.gov/pubmed/34513985
http://dx.doi.org/10.1183/23120541.00082-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419318/
https://www.ncbi.nlm.nih.gov/pubmed/34513985
http://dx.doi.org/10.1183/23120541.00082-2021

Ejemplares similares